Levetiracetam Tablet, Film Coated
Product Images NDC 72789-152

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 72789-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetamtabletsstructure (Levetiracetamtabletsstructure)

Chemical structure of Levetiracetam, showing a pyrrolidone ring with attached ethyl group, amide, and other substituents consistent with its molecular structure.*

FDA Label Image

Levetiracetamtabletsfigure1 (Levetiracetamtabletsfigure1)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis shows the percentage of patients from 0% to 45%, with the placebo group around 7.4%, the 1000 mg/day group at 37.1%, and the 3000 mg/day group at 39.6%. The number of patients in each group is indicated on the x-axis.*

FDA Label Image

Levetiracetamtabletsfigure2 (Levetiracetamtabletsfigure2)

A bar chart comparing the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The y-axis represents the percentage of patients, and each bar includes sample size (N) and an asterisk mark above Levetiracetam groups.*

FDA Label Image

Levetiracetamtabletsfigure3 (Levetiracetamtabletsfigure3)

A vertical bar graph comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The placebo group shows 14.4% of patients, while the Levetiracetam group shows 39.4%. The y-axis is labeled as percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Levetiracetamtabletsfigure4 (Levetiracetamtabletsfigure4)

A bar chart comparing the percentage of patients in two groups: Placebo (N=97) with approximately 19.6% and Levetiracetam (N=101) with approximately 44.6%. The y-axis represents the percentage of patients, ranging from 0% to 45%. An asterisk marks the Levetiracetam bar.*

FDA Label Image

Levetiracetamtabletsfigure5 (Levetiracetamtabletsfigure5)

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, with Placebo around 19.6% and Levetiracetam around 43.1%. The chart visually highlights a higher patient percentage in the Levetiracetam group.*

FDA Label Image

Levetiracetamtabletsfigure6 (Levetiracetamtabletsfigure6)

A bar chart comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The vertical axis represents the percentage of patients, ranging from 0% to 100%. The Placebo group shows 45.2%, while the Levetiracetam group shows 72.2%. An asterisk is present above the Levetiracetam bar, indicating statistical significance or emphasis.*

FDA Label Image

72789152 Label (72789152)

Levetiracetam USP 500 mg film-coated tablets label from PD-Rx Pharmaceuticals, Inc. The label indicates a package of 60 tablets with NDC 72789-152-60. It includes dosage and storage warnings, LOT L20E93, expiration date 03/2022, and instructions for taking the medication. The label features the PD-Rx Pharmaceuticals logo and a barcode as well.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.